MET and hepatocellular carcinoma: One study found c-Met-directed CAR-NK-PBMC-derived (c-MET-directed CD8α.4-1BB.DAP12.CAR-NK-PBMC) cells to demonstrate high cytotoxicity against c-MET expressing HepG2 cells, a hepatocellular carcinoma cell line [117].